Shares of Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) shot up 9.1% on Friday . The stock traded as high as $0.38 and last traded at $0.38. 2,562 shares traded hands during trading, a decline of 85% from the average session volume of 17,406 shares. The stock had previously closed at $0.35.
Spectral Medical Price Performance
The company’s 50 day simple moving average is $0.38 and its two-hundred day simple moving average is $0.41. The company has a market cap of $107.75 million, a PE ratio of -5.41 and a beta of 0.87.
Spectral Medical Company Profile
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
See Also
- Five stocks we like better than Spectral Medical
- With Risk Tolerance, One Size Does Not Fit All
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What is the Australian Securities Exchange (ASX)
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.